Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Editorial Board of Anticancer Research 2023

P.A. Abrahamsson

Department of Urology, Skåne University Hospital, Lund University, Malmö, Sweden

B. B. Aggarwal

Inflammation Research Center, San Diego, CA, USA

T. Akimoto

Division of Partical Therapy and Department of Radiation Oncology, National Cancer Center East, Kashiwa, Chiba, Japan

P.Z. Anastasiadis

Department of Cancer Biology, Mayo Cancer Center, Jacksonville, FL, USA

A. Argiris

Division of Hematology/Oncology, UT Health Science Center at San Antonio, San Antonio, TX, USA

J. P. Armand

Institut Claudius Regaud, Toulouse, France

V. I. Avramis

Division of Hematology/Oncology, Childrens Hospital, Los Angeles, CA, USA

D.T. Bau

Terry Fox Cancer Research Lab, China Medical University Hospital, Taichung, Taiwan

G. Bauer

Abteilung Virologie, Institut für Medizinische Mikrobiologie und Hygiene, Universität Freiburg, Germany

E. E. Baulieu

INSERM U488 and College de France, Le Kremlin-Bicetre, France

E. J. Benz, Jr.

Dana-Farber Cancer Institute, Boston, MA, USA

J. Bergh

Department of Clinical and Molecular Medicine, Radiumhemmet, Karolinska Institute, Stockholm, Sweden

J. Y. Blay

Medical Oncology, Centre Léon Bérard, Lyon, France

F. T. Bosman

Institute of Pathology, University of Lausanne, Switzerland

M. Bouvet

Department of Surgery, University of California San Diego, Moores Cancer Center, La Jolla, CA, USA

J. Boyd

Department of Human and Molecular Genetics, Herbert Wertheim College of Medicine, Florida Int. University, Miami, FL, USA

G. Broich

Gruppo Policlinico di Monza, Monza, Italy

Ø. S. Bruland

Department of Medical Oncology-Radiotherapy, Norwegian Radium Hospital, Oslo, Norway

J.M. Buatti

Department of Radiation Oncology, University of Iowa, Iowa City, IA, USA

M. Carbone

Cancer Research Center of Hawaii, Honolulu, HI, USA

C. Carlberg

Institute of Biomedicine, University of Eastern Finland, Kuopio, Finland

A. F. Chambers

Department of Oncology, London Regional Cancer Center, London, Ontario, Canada

P. Chandra

Abt. für Molekularbiologie, Klinikum Wolfgang Goethe-Universität, Frankfurt am Main, Germany

L. Cheng

Department of Pathology, Indiana University School of Medicine, Indianapolis, IN, USA

J.-G. Chung

Department of Biological Science and Technology, China Medical University, Taichung, Taiwan, ROC

R. Clarke

Department of Oncology, Georgetown University Medical Center, Washington, DC, USA

E. De Clercq

Rega Institute for Medical Research, Katholieke Universiteit Leuven, Belgium

A. P. Conley

Department of Sarcoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

E. P. Diamandis

Department of Pathology and Laboratory Medicine, Mount Sinai Hospital, Toronto, Ontario, Canada

G. Th. Diamandopoulos

Department of Pathology, Harvard Medical School, Boston, MA, USA

L. Egevad

Department of Pathology, Karolinska University Hospital, Stockholm, Sweden

D.W. Felsher

Division of Oncology, Stanford University School of Medicine, Stanford, CA, USA

H. Fu

Department of Pharmacology, Emory University School of Medicine, Atlanta, GA, USA

B. Fuchs

Balgrist University Hospital, Zurich, Switzerland

D. Fuchs

Center for Chemistry and Biomedicine, Innsbruck Medical University, Innsbruck, Austria

E. L. Fukumura

Steele Laboratories, Department of Radiation Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA

G. Gabbiani

Department of Pathology, University of Geneva, Switzerland

R. Ganapathi

Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC, USA

A. Giordano

Sbarro Institute for Cancer Research, Temple University, Philadelphia, PA, USA

M. Gnant

Department of Surgery, Medical University of Vienna, Vienna, Austria

R. H. Goldfarb

Trudeau Institute, Saranac Lake, NY, USA

J.S. Greenberger

Department of Radiation Oncology, University of Pittsburgh, Pittsburgh, PA, USA

A. Helland

Oslo University Hospital-Radium Hospital, Oslo, Norway

L. Helson

Sign Path Pharma, Inc., Quakertown, PA, USA

R. Henriksson

Department of Radiation Science, University of Umea, Umea, Sweeden

R. M. Hoffman

Department of Surgery, University of California, San Diego, CA, USA

P. Hohenberger

Division of Surgical Oncology & Thoracic Surgery, Mannheim University Medical Center, Mannheim, Germany

F. Janku

Monte Rosa Therapeutics, Boston, MA, USA

S. C. Jhanwar

Laboratory of Solid Tumor Genetics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA

J. V. Johannessen

Department of Pathology, the Norwegian Radium Hospital, Oslo, Norway

R. Jones

Sarcoma Unit, Royal Marsden Hospital, London, UK

B. Kaina

Institute of Toxicology, University of Mainz, Germany

D. G. Kieback

Helios Medical Center Schleswig, Schleswig, Germany

R. Klapdor

Medical Clinic, University of Hamburg, Germany

K. L. Knutson

Mayo Clinic, Jacksonville, FL, USA

H. Kobayashi

Laboratory of Molecular Theranostics, NCI/NIH, Bethesda, MD, USA

S. D. Kottaridis

Department of Virology, Hellenic Anticancer Institute, Athens, Greece

G. R. F. Krueger

Center of Anatomy II, University of Cologne Medical School, Cologne, Germany

Pat Kumar

Department of Biological Sciences, Manchester Metropolitan University, Manchester, UK

Shant Kumar

Department Pathology, University of Manchester Medical School, Manchester, UK

O. D. Laerum

Department of Pathology, the Gade Institute, University of Bergen, Norway

F. J. Lejeune

Fondation du Centre Pluridisciplinaire d’ Oncologie, CHUV, Lausanne, Switzerland

S. Linder

Department of Medicine and Health, Linköping University, Linköping, Sweden

D. M. Lopez

Department of Microbiology and Immunology, University of Miami School of Medicine, Miami, FL, USA

E. Lundgren

Unit of Applied Cell and Molecular Biology, University of Umea, Sweden

Y. Maehara

Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

J. Maher

Department of Research Oncology, Division of Cancer Studies, King’s College London School of Medicine, Guy’s Hospital Campus, London, UK

J. Marescaux

IRCAD, University of Strasbourg, France

S.S. Martin

Department of Physiology, University of Maryland, School of Medicine, Baltimore, MD, USA

S. Mitra

Houston Methodist Research Institute, Houston, TX, USA

S. Miyamoto

Department of Obstetrics and Gynecology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan

S. Moncada

Manchester Cancer Research Centre, University of Manchester, Manchester, UK

M. Mueller

Hochschule Furtwangen University, Villingen-Schwenningen, Germany

M. Namiki

Department of Integrative Cancer Therapy and Urology, Kanazawa University Graduate School of Medical Science, Kanazawa City, Ishikawa, Japan

K. Nilsson

Rudbeck Laboratory, Department of Genetics and Pathology, Uppsala University Hospital, Sweden

S. Pathak

Department of Cell Biology, University of Texas, Houston, TX, USA

J.L. Persson

Section for Experimental Cancer Research, Clinical Research Center, Lund University, Malmö, Sweden

G. J. Pilkington

Department of Cellular and Molecules Neurooncology, School of Pharmacy and Biomedical Sciences, University of Portsmouth, UK

C. D. Platsoucas

College of Sciences, Old Dominion University, Norfolk, VA, USA

A. Polliack

Department of Haematology, Hadassah University Hospital and Medical School, Jerusalem, Israel

D. Rades

Department of Radiation Oncology, University of Lübeck, Lübeck, Germany

M. Rigaud

Laboratory Biochimie et Génétique Molecules, Faculté de Médecine de Limoges, France

U. Ringborg

Department of General Oncology, Karolinska Hospital, Stockholm, Sweden

M. Roselli

Department of Medical Oncology, University of Rome “Tor Vergata”, Italy

S.T. Rosen

Comprehensive Cancer Center & Beckman Research Institute, Duarte, CA, USA

M. Schauer

Visceral and Thoracic Surgery, Augusta Krankenhaus, Düsseldorf, Germany

M. Schneider

Department of Organic Chemistry, Bergische University, Wuppertal, Germany

J. Sehouli

Department of Gynecology with Center for Oncological Surgery, Charité Comprehensive Cancer Center (CCCC), Berlin, Germany

A. Seth

Laboratory of Molecular Pathology, Sunnybrook Research Institute and University of Toronto, Ontario, Canada

G. V. Sherbet

Cancer Research Unit, University of Newcastle-upon-Tyne, UK

A. Slominski

Department of Dermatology, University of Alabama at Birmingham, Birmingham, AL, USA

G.-I. Soma

Department of Integrated and Holistic Immunology, Faculty of Medicine, Kagawa University, Kagawa, Japan

G. S. Stein

Department of Biochemistry, College of Medicine, University of Vermont, Burlington, VT, USA

T. Stigbrand

Department of Immunology, Umea University, Umea, Sweden

T. M. Theophanides

Department of Chemistry, Technical University of Athens, Greece

P. M. Ueland

Clinical Pharmacolocy Unit, Department of Pharmacology, University of Bergen, Norway

H. Van Vlierberghe

Department of Gastroenterology and Hepatology, Ghent University Hospital, Ghent, Belgium

R.G. Vile

Department of Immunology, Mayo Clinic, Rochester, MN, USA

M. Weller

Department of Neurology, University Hospital Zurich, Zurich, Switzerland

B. Westermark

Rudbecklaboratoriet, Department of Genetics and Pathology, University of Uppsala, Sweden

J. Westermarck

Center for Biotechnology, University of Turku, Turku, Finland

Y. Yen

Taipei Medical University, Taipei, Taiwan, ROC

M.R.I. Young

Ralph H. Johnson VA Medical Center, Medical University of South Carolina, Charleston, SC, USA

   

J.G. Delinasios

IIAR, Managing Editor (1981-2016)

G.J. Delinasios

IIAR, Managing Editor

 

 

Anticancer Research

© 2023 Anticancer Research

Powered by HighWire